The FDA is cracking down on direct-to-consumer pharmaceutical ads
PositiveHealth

The FDA's recent crackdown on direct-to-consumer pharmaceutical ads marks a significant shift in how these advertisements are regulated. This increased scrutiny aims to ensure that consumers receive accurate information about medications, potentially leading to better health outcomes. By holding companies accountable for misleading claims, the FDA is taking a proactive stance in protecting public health.
— Curated by the World Pulse Now AI Editorial System